World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

Login Register
World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

SJIF Impact Factor: 6.842

Abstract

DISCOID LUPUS ERYTHEMATOSUS – A REPORT OF TWO CASES

Dr. Y. Shreya*, Dr. Tirumala Kanakadurga Sripati, Dr. P. Karkuzhali, Dr. Hemalatha Ganapathy

ABSTRACT

Lupus Erythematosus is a chronic, multi-system, auto-immune disease. It manifests with diverse signs and symptoms; with localized cutaneous LE (CLE) on one end of the spectrum and severe systemic LE (SLE) on the other end. Cutaneous lupus is categorized as: Chronic Cutaneous Lupus (CCLE), Sub-acute Cutaneous Lupus (SCLE) and Acute Cutaneous Lupus (ACLE). Discoid Lupus Erythematosus (DLE) is the most common of the CCLEs. Most patients with untreated classic DLE lesions suffer indolent progression, resulting in large areas of cutaneous dystrophy and scarring alopecia, which can be psychosocially devastating. Progression to systemic lupus erythematosus (SLE) is a possibility, necessitating early diagnosis and prompt treatment with regular follow-up.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR